tadalafil has been researched along with Fetal Growth Retardation in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (45.45) | 24.3611 |
| 2020's | 12 (54.55) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, T; Kawamura, T; Tachibana, R; Takakura, S; Takeuchi, H; Tanaka, H; Tanaka, K; Yoshikawa, K | 1 |
| Deprest, J; Kumar, S; Mol, BW; Russo, F; Turner, JM | 1 |
| Enomoto, N; Ikeda, T; Katsuragi, S; Maki, S; Takakura, S; Tanaka, H; Tanaka, K | 1 |
| Aoki, S; Aoki, Y; Endo, M; Ikeda, T; Kasai, M; Kawamura, H; Kikuchi, N; Kinjo, T; Kotani, T; Kotera, M; Maegawa, Y; Maki, S; Nagao, K; Nakamura, K; Nakata, M; Nii, M; Nishimura, Y; Ogura, T; Sekizawa, A; Suga, S; Takakura, S; Takano, M; Tamaru, S; Tanaka, H; Tanaka, K; Tanaka, Y; Ushida, T; Yasuhi, I; Yasui, O; Yoshida, Y | 1 |
| Ding, H; Mao, J; Wu, N; Yao, F | 1 |
| Enomoto, N; Hirayama, M; Ikeda, T; Kitamura, A; Kondo, E; Magawa, S; Maki, S; Nii, M; Okamoto, K; Sawada, H; Takakura, S; Tanaka, H; Tanaka, K; Tsuji, M; Yodoya, N | 1 |
| Baker, PN; Ganzevoort, W; Gluud, C; Groom, KM; Jakobsen, JC; Kariya, CT; Kenny, LC; Leemhuis, AG; Magee, LA; Mol, BWJ; Papageorghiou, AT; Pels, A; Sharp, AN; von Dadelszen, P | 1 |
| Hashizume, Y; Ikeda, T; Sato, E; Sato, H; Sekimoto, A; Takahashi, N; Tanaka, K | 1 |
| Endoh, M; Furuhashi, F; Ikeda, T; Kaneda, MK; Kimura, T; Kotani, T; Magawa, S; Maki, S; Nii, M; Nishimura, Y; Ogura, T; Sekizawa, A; Tanaka, H; Tanaka, K; Tsuji, M | 1 |
| Enomoto, N; Ikeda, T; Katsuragi, S; Maki, S; Nii, M; Takakura, S; Tanaka, H; Tanaka, K; Toriyabe, K; Tsuchiya, K | 1 |
| Ikeda, T; Katsuragi, S; Kawamura, T; Maki, S; Tachibana, R; Takeuchi, H; Tanaka, H; Tanaka, K; Toriyabe, K; Yoshikawa, K | 1 |
| Ikeda, T; Kubo, M; Maki, S; Nii, M; Tanaka, H; Umekawa, T | 1 |
| Aggarwal, S; Ambalavanan, N; Bradley, WE; Carlisle, MA; Dell'Italia, L; Doran, S; Ford, DA; Jilling, T; Lam, A; Lambert, JA; Matalon, S; Patel, RP; Ren, C | 1 |
| Ikeda, T; Kamimoto, Y; Kondo, E; Kubo, M; Maki, S; Murabayashi, N; Nii, M; Osato, K; Tanaka, H; Umekawa, T | 1 |
| Hosoda, H; Ikeda, T; Ikemura, K; Kamimoto, Y; Katayama, K; Kondo, E; Kubo, M; Ma, N; Maki, S; Miyoshi, T; Nii, M; Okuda, M; Osato, K; Tanaka, H; Tanaka, K; Umekawa, T; Yoshida, T; Yoshikawa, K | 1 |
| Hatano, F; Ikeda, T; Kamimoto, Y; Kubo, M; Magawa, S; Maki, S; Nii, M; Osato, K; Tanaka, H; Tanaka, K; Tsuji, M; Umekawa, T | 1 |
| Estrada, SM; Ieronimakis, N; Napolitano, PG; Reed, LC; Schmiedecke, SS; Villazana-Kretzer, DL; Walton, RB | 1 |
| Endoh, M; Ikeda, T; Kamimoto, Y; Kimura, T; Kodera, M; Kotani, T; Kubo, M; Maki, S; Minamide, C; Nakamura, M; Nii, M; Nishikawa, M; Nishimura, Y; Ogura, T; Osato, K; Sekizawa, A; Tamaru, S; Tanaka, H; Tanaka, K; Umekawa, T | 1 |
| Endoh, M; Furuhashi, F; Hosoda, H; Ikeda, T; Ikemura, K; Kamimoto, Y; Kaneda, MK; Kato, I; Kimura, T; Kondo, E; Ma, N; Magawa, S; Maki, S; Miyoshi, T; Nii, M; Okuda, M; Owa, T; Shimada, K; Tachibana, R; Tanaka, H; Tanaka, K; Tsuji, M; Umekawa, T; Yoshikawa, K | 1 |
| Furuhashi, F; Ikeda, T; Kondo, E; Kubo, M; Magawa, S; Maki, S; Nii, M; Tanaka, H; Tanaka, K | 1 |
| Ikeda, T; Kamimoto, Y; Kubo, M; Murabayashi, N; Nii, M; Osato, K; Sakamoto, M; Tanaka, H; Umekawa, T | 1 |
| Ikeda, T; Kamimoto, Y; Kubo, M; Maekawa, Y; Murabayashi, N; Nii, M; Osato, K; Tanaka, H; Umekawa, T | 1 |
2 review(s) available for tadalafil and Fetal Growth Retardation
| Article | Year |
|---|---|
Phosphodiesterase-5 inhibitors in pregnancy: Systematic review and meta-analysis of maternal and perinatal safety and clinical outcomes.
Topics: Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Fetal Distress; Fetal Growth Retardation; Humans; Hypertension, Pulmonary; Infant, Newborn; Phosphodiesterase 5 Inhibitors; Pregnancy; Sildenafil Citrate; Tadalafil | 2022 |
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy.
Topics: Female; Fetal Death; Fetal Growth Retardation; Humans; Infant, Newborn; Nitric Oxide; Nitroglycerin; Placenta; Pregnancy; Premature Birth; Sildenafil Citrate; Tadalafil | 2023 |
6 trial(s) available for tadalafil and Fetal Growth Retardation
| Article | Year |
|---|---|
Tadalafil treatment for fetuses with early-onset growth restriction: a protocol for a multicentre, randomised, placebo-controlled, double-blind phase II trial (TADAFER IIb).
Topics: Clinical Trials, Phase II as Topic; Double-Blind Method; Female; Fetal Growth Retardation; Fetus; Gestational Age; Humans; Infant, Newborn; Multicenter Studies as Topic; Pregnancy; Randomized Controlled Trials as Topic; Tadalafil; Treatment Outcome | 2022 |
Tadalafil treatment for preeclampsia (medication in preeclampsia; MIE): a multicenter phase II clinical trial.
Topics: Female; Fetal Growth Retardation; Humans; Phosphodiesterase 5 Inhibitors; Pre-Eclampsia; Pregnancy; Tadalafil | 2021 |
Safety and dose-finding trial of tadalafil administered for fetal growth restriction: A phase-1 clinical study.
Topics: Adult; Female; Fetal Death; Fetal Growth Retardation; Humans; Phosphodiesterase 5 Inhibitors; Pregnancy; Premature Birth; Tadalafil | 2017 |
Cardiac function and tadalafil used for treating fetal growth restriction in pregnant women without cardiovascular disease.
Topics: Adult; Female; Fetal Growth Retardation; Heart; Humans; Pregnancy; Tadalafil; Vasodilator Agents | 2019 |
TADAFER II: Tadalafil treatment for fetal growth restriction - a study protocol for a multicenter randomised controlled phase II trial.
Topics: Clinical Trials, Phase II as Topic; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Japan; Multicenter Studies as Topic; Perinatal Mortality; Phosphodiesterase 5 Inhibitors; Pregnancy; Prenatal Care; Prospective Studies; Randomized Controlled Trials as Topic; Tadalafil; Ultrasonography, Doppler | 2018 |
Phase-1 clinical study of tadalafil administered for selective fetal growth restriction in twin pregnancy.
Topics: Female; Fetal Growth Retardation; Humans; Infant, Newborn; Placenta; Pregnancy; Pregnancy, Twin; Tadalafil; Twins, Monozygotic | 2021 |
14 other study(ies) available for tadalafil and Fetal Growth Retardation
| Article | Year |
|---|---|
Tadalafil Treatment of Mice with Fetal Growth Restriction and Preeclampsia Improves Placental mTOR Signaling.
Topics: Animals; Female; Fetal Growth Retardation; Mice; NG-Nitroarginine Methyl Ester; Placenta; Pre-Eclampsia; Pregnancy; Signal Transduction; Tadalafil; TOR Serine-Threonine Kinases | 2022 |
Maternal blood concentration of tadalafil in pregnancy: Comparison of pregnant and non-pregnant women.
Topics: Female; Fetal Growth Retardation; Humans; Placental Circulation; Pregnancy; Pregnant Women; Tadalafil | 2022 |
Tadalafil for fetal growth restriction concerning integrity of data.
Topics: Female; Fetal Growth Retardation; Humans; Phosphodiesterase 5 Inhibitors; Tadalafil | 2023 |
Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction.
Topics: Biometry; Child; Female; Fetal Growth Retardation; Humans; Infant; Infant, Newborn; Pregnancy; Prognosis; Retrospective Studies; Tadalafil; Ultrasonography, Prenatal | 2023 |
Tadalafil alleviates preeclampsia and fetal growth restriction in RUPP model of preeclampsia in mice.
Topics: Animals; Blood Pressure; Disease Models, Animal; Female; Fetal Growth Retardation; Hypertension; Male; Mice; Phosphodiesterase 5 Inhibitors; Pre-Eclampsia; Pregnancy; Tadalafil | 2020 |
Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction.
Topics: Female; Fetal Growth Retardation; Humans; Hypoxia; Pregnancy; Sirolimus; Tadalafil; TOR Serine-Threonine Kinases | 2020 |
Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring.
Topics: Adipocytes; Animals; Diet, High-Fat; Female; Fetal Development; Fetal Growth Retardation; Glucose Tolerance Test; Hypertension; Hypertrophy; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Non-alcoholic Fatty Liver Disease; Pregnancy; Prenatal Exposure Delayed Effects; Tadalafil | 2021 |
Treatment using tadalafil for severe pre-eclampsia with fetal growth restriction.
Topics: Adult; Female; Fetal Growth Retardation; Humans; Phosphodiesterase 5 Inhibitors; Pre-Eclampsia; Pregnancy; Tadalafil | 2017 |
Mechanisms and Treatment of Halogen Inhalation-Induced Pulmonary and Systemic Injuries in Pregnant Mice.
Topics: Animals; Bromine; Disease Models, Animal; Female; Fetal Growth Retardation; Hypertension; Inhalation Exposure; Lung Injury; Mice; Oxidants; Phosphodiesterase 5 Inhibitors; Placenta; Pre-Eclampsia; Pregnancy; Systemic Inflammatory Response Syndrome; Tadalafil; Treatment Outcome | 2017 |
Tadalafil Improves L-NG-Nitroarginine Methyl Ester-Induced Preeclampsia With Fetal Growth Restriction-Like Symptoms in Pregnant Mice.
Topics: Animals; Blood Pressure; Cyclic GMP; Enzyme Inhibitors; Female; Fetal Development; Fetal Growth Retardation; Kidney; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Placenta; Pre-Eclampsia; Pregnancy; Proteinuria; Tadalafil | 2017 |
Evaluation of Sildenafil and Tadalafil for Reversing Constriction of Fetal Arteries in a Human Placenta Perfusion Model.
Topics: Arteries; Female; Fetal Growth Retardation; Humans; Perfusion; Phosphodiesterase 5 Inhibitors; Placenta; Pregnancy; Sildenafil Citrate; Tadalafil; Vasoconstriction | 2018 |
Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Brain; Disease Models, Animal; Female; Fetal Growth Retardation; Hypoxia; Mice; Placenta; Pre-Eclampsia; Pregnancy; Tadalafil; Treatment Outcome; Vasodilator Agents | 2019 |
Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report.
Topics: Adult; Asian People; Cesarean Section; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Male; Oligohydramnios; Phosphodiesterase 5 Inhibitors; Pregnancy; Pregnancy Outcome; Tadalafil; Ultrasonography, Prenatal | 2016 |
Retrospective study of tadalafil for fetal growth restriction: Impact on maternal and perinatal outcomes.
Topics: Adult; Birth Weight; Delivery, Obstetric; Female; Fetal Growth Retardation; Humans; Outcome Assessment, Health Care; Phosphodiesterase 5 Inhibitors; Pregnancy; Retrospective Studies; Tadalafil | 2017 |